187 related articles for article (PubMed ID: 32885534)
1. Attributable mortality of candidemia after introduction of echinocandins.
Cornely FB; Cornely OA; Salmanton-García J; Koehler FC; Koehler P; Seifert H; Wingen-Heimann S; Mellinghoff SC
Mycoses; 2020 Dec; 63(12):1373-1381. PubMed ID: 32885534
[TBL] [Abstract][Full Text] [Related]
2. Attributable mortality of candidemia at a German tertiary hospital from 1997 to 2001 before the introduction of echinocandins.
Blankenheim Y; Salmanton-García J; Seifert H; Cornely OA; Koehler P
Mycoses; 2022 Feb; 65(2):211-221. PubMed ID: 34847247
[TBL] [Abstract][Full Text] [Related]
3. Initial antifungal strategy does not correlate with mortality in patients with candidemia.
Murri R; Scoppettuolo G; Ventura G; Fabbiani M; Giovannenze F; Taccari F; Milozzi E; Posteraro B; Sanguinetti M; Cauda R; Fantoni M
Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):187-93. PubMed ID: 26634352
[TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
[TBL] [Abstract][Full Text] [Related]
6. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
Doğan Ö; Yeşilkaya A; Menekşe Ş; Güler Ö; Karakoç Ç; Çınar G; Kapmaz M; Aydın M; Keske Ş; Şahin S; Hacıseyitoğlu D; Yalçın D; Tekin S; Ataç N; Albayrak Ö; Aksu ED; Can F; Ergönül Ö
Int J Antimicrob Agents; 2020 Jul; 56(1):105992. PubMed ID: 32335275
[TBL] [Abstract][Full Text] [Related]
7. Candida infections in non-neutropenic children after the neonatal period.
Hacimustafaoglu M; Celebi S
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
[TBL] [Abstract][Full Text] [Related]
8. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
9. Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia.
Eschenauer GA; Nguyen MH; Clancy CJ
Ann Pharmacother; 2015 Sep; 49(9):1068-74. PubMed ID: 26104051
[TBL] [Abstract][Full Text] [Related]
10. Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study.
Garnacho-Montero J; Díaz-Martín A; Cantón-Bulnes L; Ramírez P; Sierra R; Arias-Verdú D; Rodríguez-Delgado M; Loza-Vázquez A; Rodriguez-Gomez J; Gordón M; Estella Á; García-Garmendia JL
Crit Care Med; 2018 Mar; 46(3):384-393. PubMed ID: 29189345
[TBL] [Abstract][Full Text] [Related]
11. Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score Analysis.
Cuervo G; Garcia-Vidal C; Puig-Asensio M; Vena A; Meije Y; Fernández-Ruiz M; González-Barberá E; Blanco-Vidal MJ; Manzur A; Cardozo C; Gudiol C; Montejo JM; Pemán J; Ayats J; Aguado JM; Muñoz P; Marco F; Almirante B; Carratalà J;
Clin Infect Dis; 2017 May; 64(10):1374-1379. PubMed ID: 28329281
[TBL] [Abstract][Full Text] [Related]
12. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia.
Calvo B; Melo AS; Perozo-Mena A; Hernandez M; Francisco EC; Hagen F; Meis JF; Colombo AL
J Infect; 2016 Oct; 73(4):369-74. PubMed ID: 27452195
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of echinocandins versus fluconazole for treatment of persistent candidemia: A time-dependent analysis.
Lin KY; Chen PY; Chuang YC; Wang JT; Sun HY; Sheng WH; Chen YC; Chang SC
J Infect; 2018 Sep; 77(3):242-248. PubMed ID: 29932963
[TBL] [Abstract][Full Text] [Related]
14. Impact of biofilm production by Candida species and antifungal therapy on mortality of patients with candidemia.
Lee CH; Chen YC; Chen IL; Chen FJ; Chien CC
Mycoses; 2020 Dec; 63(12):1382-1391. PubMed ID: 32910518
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).
Chiotos K; Vendetti N; Zaoutis TE; Baddley J; Ostrosky-Zeichner L; Pappas P; Fisher BT
J Antimicrob Chemother; 2016 Dec; 71(12):3536-3539. PubMed ID: 27494929
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
17. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
Fernández-Ruiz M; Aguado JM; Almirante B; Lora-Pablos D; Padilla B; Puig-Asensio M; Montejo M; García-Rodríguez J; Pemán J; Ruiz Pérez de Pipaón M; Cuenca-Estrella M; ; ;
Clin Infect Dis; 2014 May; 58(10):1413-21. PubMed ID: 24642553
[TBL] [Abstract][Full Text] [Related]
18. Impact of empirical treatment with antifungal agents on survival of patients with candidemia.
Poves-Alvarez R; Cano-Hernández B; Muñoz-Moreno MF; Balbás-Alvarez S; Román-García P; Gómez-Sánchez E; Martínez-Rafael B; Gómez-Pesquera E; Lorenzo-López M; Alvarez-Fuente E; de la Varga O; Flores M; Eiros JM; Tamayo E; Heredia-Rodríguez M
Rev Esp Quimioter; 2019 Feb; 32(1):6-14. PubMed ID: 30499639
[TBL] [Abstract][Full Text] [Related]
19. Molecular Analysis of Resistance and Detection of Non-Wild-Type Strains Using Etest Epidemiological Cutoff Values for Amphotericin B and Echinocandins for Bloodstream Candida Infections from a Tertiary Hospital in Qatar.
Taj-Aldeen SJ; Salah H; Perez WB; Almaslamani M; Motyl M; AbdulWahab A; Healey KR; Perlin DS
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941644
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
